B-type natriuretic peptide: Perioperative patterns in congenital heart disease

Congenital Heart Disease

Volumn 5, Issue 3, 2010, Pages 243-255

  Niedner, Matthew F ^a,b,e   Foley, Jennifer L ^a   Riffenburgh, Robert H ^c   Bichell, David P ^f   Peterson, Bradley M ^a   Rodarte, Alexander ^d  

^a RADY CHILDREN'S HOSPITAL   (United States)

^b NAVAL MEDICAL CENTER SAN DIEGO   (United States)

^c SAN DIEGO STATE UNIVERSITY   (United States)

^d University of California   (United States)

^e UNIVERSITY OF MICHIGAN   (United States)

^f VANDERBILT UNIVERSITY   (United States)

Author keywords

Congenital heart defects; Congestive heart failure; Low Cardiac Output; Natriuretic peptides; Nesiritide; Perioperative Care

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; BIOLOGICAL MARKER;

ADOLESCENT; ARTICLE; ARTIFICIAL VENTILATION; CENTRAL VENOUS PRESSURE; CHILD; CONGENITAL HEART DISEASE; CONTROLLED STUDY; FEMALE; FONTAN PROCEDURE; FORWARD HEART FAILURE; HEART ARREST; HEART FAILURE; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; INFANT; INOTROPISM; INTENSIVE CARE UNIT; INTRAOPERATIVE PERIOD; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEWBORN; PERFUSION; PERIOPERATIVE PERIOD; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; SCHOOL CHILD; URINE VOLUME; AGE; BLOOD; CASE CONTROL STUDY; HEART DEFECTS, CONGENITAL; HEART SURGERY; HOSPITAL; LENGTH OF STAY; PREDICTIVE VALUE; PROSPECTIVE STUDY; SEVERITY OF ILLNESS INDEX; TIME; UNITED STATES; YOUNG ADULT;

ADOLESCENT; AGE FACTORS; BIOLOGICAL MARKERS; CALIFORNIA; CARDIAC SURGICAL PROCEDURES; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; HEART DEFECTS, CONGENITAL; HOSPITALS, PEDIATRIC; HUMANS; INFANT; INFANT, NEWBORN; LENGTH OF STAY; NATRIURETIC PEPTIDE, BRAIN; PERIOPERATIVE CARE; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TIME FACTORS; YOUNG ADULT;

EID: 77954109674     PISSN: 1747079X     EISSN: 17470803     Source Type: Journal    
DOI: 10.1111/j.1747-0803.2010.00396.x     Document Type: Article

References (49)

1. Westerlind A, Wahlander H, Berggren H, Lundberg PA, Holmgren D. Plasma levels of natriuretic peptide type B and A in children with heart disease with different types of cardiac load or systolic dysfunction. Clin Physiol Funct Imaging 2008, 28:277-284.
2. Maisel A. B-type natriuretic peptide levels: a potential novel " white count" for congestive heart failure. J Card Fail 2001, 7:183-193.
3. Harrison A, Morrison LK, Krishnaswamy P. B-type natriuretic peptide predicts future cardiac events in patients presenting to the emergency department with dyspnea. Ann Emerg Med 2002, 39:131-138.
4. Cheng V, Kazanagra R, Garcia A. A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study. J Am Coll Cardiol 2001, 37:386-391.
5. Berger R, Huelsman M, Strecker K. B-type natriuretic peptide predicts sudden death in patients with chronic heart failure. Circulation 2002, 105:2392-2397.
6. Price JF, Thomas AK, Grenier M. B-type natriuretic peptide predicts adverse cardiovascular events in pediatric outpatients with chronic left ventricular systolic dysfunction. Circulation 2006, 114:1063-1069.
7. Tan LH, Jefferies JL, Liang JF. Concentrations of brain natriuretic peptide in the plasma predicts outcomes of treatment of children with decompensated heart failure admitted to the intensive care unit. Cardiol Young 2007, 17:397-406.
8. Hsu JH, Keller RL, Chikovani O. B-type natriuretic peptide levels predict outcome after neonatal cardiac surgery. J Thorac Cardiovasc Surg 2007, 134:939-945.
9. Hsu JH, Oishi PE, Keller RL. Perioperative B-type natriuretic peptide levels predict outcome after bidirectional cavopulmonary anastomosis and total cavopulmonary connection. J Thorac Cardiovasc Surg 2008, 135:746-753.
10. Costello JM, Goodman DM, Green TP. A review of the natriuretic hormone system's diagnostic and therapeutic potential in critically ill children. Pediatr Crit Care Med 2006, 7:308-318.
11. Oishi PE, Fineman JR. BNP for pediatrics-not quite ready for primetime. Pediatr Crit Care Med 2006, 7:388-389.
12. Davis GK, Bamforth F, Sarpal A. B-type natriuretic peptide in pediatrics. Clin Biochem 2006, 39:600-605.
13. Nir A, Nasser N. Clinical value of NT-ProBNP and BNP in pediatric cardiology. J Card Fail 2005, 11:S76-S80. suppl
14. Berry JG, Askovich B, Shaddy RE, Hawkins JA, Cowley CG. Prognostic value of B-type natriuretic peptide in surgical palliation of children with single-ventricle congenital heart disease. Pediatr Cardiol 2008, 29:70-75.
15. Tobias JD, Lindblade CL, Schamberger MS. B-type natriuretic peptide monitoring in the pediatric ICU population. Paediatr Anaesth 2007, 17:793-799.
16. El-Khuffash A, Molloy EJ. Are B-type natriuretic peptide (BNP) and N-terminal-pro-BNP useful in neonates? Arch Dis Child Fetal Neonatal Ed 2007, 92:F320-F324.
17. Maisel AS. Nesiritide: a new therapy for the treatment of heart failure. Cardiovasc Toxicol 2003, 3:37-42.
18. Jefferies JL, Denfield SW, Price JF. A prospective evaluation of nesiritide in the treatment of pediatric heart failure. Pediatr Cardiol 2006, 27:402-407.
19. Jefferies JL, Price JF, Denfield SW. Safety and efficacy of nesiritide in pediatric heart failure. J Card Fail 2007, 13:541-548.
20. Sackner-Bernstein JD, Kowalski M, Fox M, Aaronson K. Short-term risk of death after treatment with nesiritide for decompensated heart failure: a pooled analysis of randomized controlled trials. JAMA 2005, 293:1900-1905.
21. Sackner-Bernstein JD, Skopicki HA, Aaronson KD. Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure. Circulation 2005, 111:1487-1491.
22. Topol EJ. Nesiritide-not verified. N Engl J Med 2005, 353:113-116.
23. Hernandez AF, O'Connor CM, Starling RC. Rationale and design of the Acute Study of ClinicalEffectiveness of Nesiritide in Decompensated Heart Failure Trial (ASCEND-HF). Am Heart J 2009, 157:271-277.
24. Law YM, Ettedgui J, Beerman L, Maisel A, Tofovic S. Comparison of plasma B-type natriuretic peptide levels in single ventricle patients with systemic ventricle heart failure versus isolated cavopulmonary failure. Am J Cardiol 2006, 98:520-524.
25. Law YM, Keller BB, Feingold BM, Boyle GJ. Usefulness of plasma B-type natriuretic peptide to identify ventricular dysfunction in pediatric and adult patients with congenital heart disease. Am J Cardiol 2005, 95:474-478.
26. Sun LS, Dominguez C, Mallavaram NA, Quaegebeur JM. Dysfunction of atrial and B-type natriuretic peptides in congenital univentricular defects. J Thorac Cardiovasc Surg 2005, 129:1104-1110.
27. Ozhan H, Albayrak S, Uzun H, Ordu S, Kaya A, Yazici M. Correlation of plasma B-type natriuretic peptide with shunt severity in patients with atrial or ventricular septal defect. Pediatr Cardiol 2007, 28:272-275.
28. Holmgren D, Westerlind A, Berggren H, Lundberg PA, Wahlander H. Increased natriuretic peptide type B level after the second palliative step in children with univentricular hearts with right ventricular morphology but not left ventricular morphology. Pediatr Cardiol 2008, 29:786-792.
29. Koch AM, Zink S, Singer H, Dittrich S. B-type natriuretic peptide levels in patients with functionally univentricular hearts after total cavopulmonary connection. Eur J Heart Fail 2008, 10:60-62.
30. Shih CY, Sapru A, Oishi P. Alterations in plasma B-type natriuretic peptide levels after repair of congenital heart defects: a potential perioperative marker. J Thorac Cardiovasc Surg 2006, 131:632-638.
31. Koch A, Kitzsteiner T, Zink S, Cesnjevar R, Singer H. Impact of cardiac surgery on plasma levels of B-type natriuretic peptide in children with congenital heart disease. Int J Cardiol 2007, 114:339-344.
32. Koch A, Zink S, Singer H. B-type natriuretic peptide in paediatric patients with congenital heart disease. Eur Heart J 2006, 27:861-866.
33. Lechner E, Gitter R, Mair R. Aminoterminal brain natriuretic peptide levels in children and adolescents after Fontan operation correlate with congestive heart failure. Pediatr Cardiol 2008, 29:901-905.
34. Gibson SC, Payne CJ, Byrne DS, Berry C, Dargie HJ, Kingsmore DB. B-type natriuretic peptide predicts cardiac morbidity and mortality after major surgery. Br J Surg 2007, 94:903-909.
35. Pene F, Courtine E, Cariou A, Mira JP. Toward theragnostics. Crit Care Med 2009, 37(1):S50-S58. suppl
36. Hoffman TM, Wernovsky G, Atz AM. Prophylactic intravenous use of milrinone after cardiac operation in pediatrics (PRIMACORP) study. Prophylactic intravenous use of milrinone after cardiac operation in pediatrics. Am Heart J 2002, 143:15-21.
37. Koch A, Singer H. Normal values of B type natriuretic peptide in infants, children, and adolescents. Heart 2003, 89:875-878.
38. Ationu A, Singer DR, Smith A, Elliott M, Burch M, Carter ND. Studies of cardiopulmonary bypass in children: implications for the regulation of brain natriuretic peptide. Cardiovasc Res 1993, 27:1538-1541.
39. Mair J. Biochemistry of B-type natriuretic peptide-where are we now? Clin Chem Lab Med 2008, 46:1507-1514.
40. Das SR, Abdullah SM, Leonard D. Association between renal function and circulating levels of natriuretic peptides (from the Dallas Heart Study). Am J Cardiol 2008, 102:1394-1398.
41. Claudius I, Lan YT, Chang RK, Wetzel GT, Alejos J. Usefulness of B-type natriuretic peptide as a noninvasive screening tool for cardiac allograft pathology in pediatric heart transplant recipients. Am J Cardiol 2003, 92:1368-1370.
42. Cowley CG, Bradley JD, Shaddy RE. B-type natriuretic peptide levels in congenital heart disease. Pediatr Cardiol 2004, 25:336-340.
43. Hjortdal VE, Stenbog EV, Ravn HB. Neurohormonal activation late after cavopulmonary connection. Heart 2000, 83:439-443.
44. Koulouri S, Acherman RJ, Wong PC, Chan LS, Lewis AB. Utility of B-type natriuretic peptide in differentiating congestive heart failure from lung disease in pediatric patients with respiratory distress. Pediatr Cardiol 2004, 25:341-346.
45. Suda K, Matsumura M, Matsumoto M. Clinical implication of plasma natriuretic peptides in children with ventricular septal defect. Pediatr Int 2003, 45:249-254.
46. Simsic JM, Scheurer M, Tobias JD. Perioperative effects and safety of nesiritide following cardiac surgery in children. J Intensive Care Med 2006, 21:22-26.
47. Simsic JM, Mahle WT, Cuadrado A, Kirshbom PM, Maher KO. Hemodynamic effects and safety of nesiritide in neonates with heart failure. J Intensive Care Med 2008, 23:389-395.
48. Mahle WT, Cuadrado AR, Kirshbom PM, Kanter KR, Simsic JM. Nesiritide in infants and children with congestive heart failure. Pediatr Crit Care Med 2005, 6:543-546.
49. Ryan A, Rosen DA, Tobias JD. Preliminary experience with nesiritide in pediatric patients less than 12 months of age. J Intensive Care Med 2008, 23:321-328.